AKT1 and neoplasm: Inhibition of PI3K/AKT/mTOR signaling by miR-99a reduced cell invasion of EC, and MK2206, an allosteric AKT inhibitor, decreased tumor growth and invasion in patient-derived xenografts of EC [51,52].